Vaccine breakthrough stops cancer returning in trial

A new vaccine developed by Merck and Moderna has shown promising results in stopping skin cancer from returning in trial patients. The vaccine, Intismeran, targets high-risk melanoma after surgery, but experts urge caution as full results await peer review and regulatory approval.

Full story and more reels: https://newsreel.video

#news #breaking #cancerresearch #melanoma #healthcare #vaccines #immunotherapy